Immunocore Historical Income Statement
| IMCR Stock | USD 26.12 1.59 6.48% |
Historical analysis of Immunocore Holdings income statement accounts such as Net Interest Income of 7.1 M or Interest Income of 26.9 M can show how well Immunocore Holdings performed in making a profits. Evaluating Immunocore Holdings income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Immunocore Holdings's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Immunocore Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immunocore Holdings is a good buy for the upcoming year.
Immunocore |
About Immunocore Income Statement Analysis
Immunocore Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Immunocore Holdings shareholders. The income statement also shows Immunocore investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Immunocore Holdings Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Immunocore Holdings generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most accounts from Immunocore Holdings' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Immunocore Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.At this time, Immunocore Holdings' Total Other Income Expense Net is relatively stable compared to the past year.
| 2022 | 2023 | 2024 | 2025 (projected) | Depreciation And Amortization | 5.3M | 4.1M | 1.3M | 1.3M | Interest Income | 3.2M | 12.5M | 25.6M | 26.9M |
Immunocore Holdings income statement Correlations
Click cells to compare fundamentals
Immunocore Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunocore Holdings income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 3.1M | 5.8M | 7.7M | 5.2M | 18.8M | 19.8M | |
| Other Operating Expenses | 119.4M | 161.7M | 183.3M | 309.1M | 380.7M | 399.7M | |
| Net Income Applicable To Common Shares | (103.9M) | (74.1M) | (131.5M) | (41.2M) | (37.1M) | (39.0M) | |
| Income Tax Expense | (13.3M) | (9.4M) | (2.9M) | (5.6M) | (1.9M) | (1.9M) | |
| Ebit | (111.6M) | (174.3M) | (43.7M) | (55.7M) | (71.8M) | (75.4M) | |
| Tax Provision | (13.3M) | (9.4M) | (2.9M) | 2.4M | (1.9M) | (1.9M) | |
| Interest Income | 706K | 47K | 3.2M | 12.5M | 25.6M | 26.9M | |
| Depreciation And Amortization | 9.0M | 7.6M | 5.3M | 4.1M | 1.3M | 1.3M | |
| Selling General Administrative | 45.7M | 88.4M | 93.7M | 154.9M | 155.8M | 96.9M | |
| Total Revenue | 30.1M | 26.5M | 143.7M | 249.4M | 310.2M | 325.7M | |
| Gross Profit | (44.7M) | (46.7M) | 143.3M | 248.4M | 307.5M | 322.8M | |
| Operating Income | (86.2M) | (135.2M) | (39.6M) | (59.6M) | (70.5M) | (74.0M) | |
| Net Income From Continuing Ops | (74.1M) | (131.5M) | (41.2M) | (54.1M) | (51.1M) | (53.6M) | |
| Research Development | 74.8M | 73.2M | 89.2M | 163.5M | 222.2M | 126.7M | |
| Ebitda | (102.6M) | (166.7M) | (38.4M) | (51.6M) | (70.5M) | (74.0M) | |
| Total Operating Expenses | 119.4M | 161.7M | 182.9M | 308.0M | 377.9M | 221.9M | |
| Reconciled Depreciation | 9.0M | 7.0M | 6.1M | 5.3M | 4.2M | 5.4M | |
| Income Before Tax | (87.4M) | (140.9M) | (44.1M) | (60.9M) | (52.9M) | (55.6M) | |
| Total Other Income Expense Net | (1.2M) | 33.7M | 5.8M | (1.2M) | 17.5M | 18.4M | |
| Net Income | (74.1M) | (131.5M) | (41.2M) | (55.3M) | (51.1M) | (53.6M) | |
| Cost Of Revenue | 74.8M | 73.2M | 454K | 1.0M | 2.7M | 2.6M |
Pair Trading with Immunocore Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immunocore Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with Immunocore Stock
Moving against Immunocore Stock
The ability to find closely correlated positions to Immunocore Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immunocore Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immunocore Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immunocore Holdings to buy it.
The correlation of Immunocore Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunocore Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunocore Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immunocore Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.